Opdivo and Keytruda approved in new lung cancer usesThe FDA has approved Merck’s Keytruda (pembrolizumab) as a combination treatment for metastatic nonsquamous non-small cell lung cancer Share XOpdivo and Keytruda approved in new lung cancer useshttps://pharmaphorum.com/news/bmss-opdivo-approved-lung-cancer/